Abstract
A delicate balance exists between the process of carcinogenesis and tissue regeneration. A number of malignant tumours are considered the outcome of an impaired or incomplete regeneration process, resulting in persistently dividing cells. Regeneration-competent tissues and animals are able to prevent and counteract growth abnormalities and seem to have a low vulnerability to chemical carcinogenesis. Cancer cell survival depends, among other things, on various redox-related mechanisms, which are targets of currently developed therapies. Disadvantages of these therapies are a lack of specificity and drug resistance. As the majority of these redox-related mechanisms also play an important role in successful and coordinated cell functioning and reproduction, the regeneration process offers a unique parallel context for modern cancer research. This review focuses on the interconnections between regeneration and carcinogenesis and how an understanding of regenerative forces and redox-controlled mechanisms could contribute to the identification of new therapeutic targets to block the growth and survival of cancer cells.
Original language | English |
---|---|
Pages (from-to) | 1414-1437 |
Number of pages | 24 |
Journal | Current Drug Targets |
Volume | 17 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2016 |
Keywords
- Anticarcinogenic therapies
- carcinogenesis
- redox-related mechanisms
- regeneration
- stem cells
- NF-KAPPA-B
- EPITHELIAL-MESENCHYMAL TRANSITION
- OXYGEN SPECIES ACCUMULATION
- AXON REGENERATION REQUIRES
- INDUCIBLE FACTOR 1-ALPHA
- INHIBITS TUMOR-GROWTH
- OXIDATIVE STRESS
- BREAST-CANCER
- STEM-CELLS
- PLANARIAN REGENERATION